GLP-1 injections at a Florida med spa: what the science says

What did @historiasdelesbianismogi actually say?

Honestly? It's nearly impossible to tell. The transcript here is garbled beyond recognition, likely the result of auto-captioning software failing on a Spanish-language or bilingual video. What we get is a string of disconnected phrases: references to eating, vague statements about happiness, and what appears to be a name introduction. No coherent medical claim survives the transcription.

What is clear from the caption is that this video is promoting a medspa, Aimar MedSpa, located in Orange City, Florida, with direct phone numbers for two individuals named Yelenis and Vanessa. The hashtags include #weightloss and #armonizacionfacial (facial harmonization), alongside GLP-1-adjacent content signals. This is a promotional post for a medical aesthetics and likely weight loss service provider, not an educational video.

Because we cannot verify what was actually said in the video, we are evaluating the promotional framing and context rather than specific spoken claims.

Does the science back this up?

There is no scientific claim to evaluate directly from this transcript. What we can assess is the broader context: a medspa promoting weight loss services on TikTok, targeting Spanish-speaking communities in Florida.

GLP-1 receptor agonists like semaglutide and tirzepatide do have strong clinical backing for weight loss. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide produced up to 22.5% body weight reduction over 72 weeks. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg produced roughly 14.9% body weight loss versus 2.4% with placebo.

But clinical trial results don't automatically translate to medspa settings. Medspas operate under varying levels of physician oversight depending on state law. Florida requires physician oversight for prescribing, but enforcement of how that works in practice at aesthetic clinics varies. Patients should ask pointed questions about who is prescribing, what's being prescribed, and whether it's a brand-name or compounded product.

What did they get wrong (or right)?

We cannot credit or criticize specific spoken claims because the transcript is incoherent due to what appears to be a transcription failure, not necessarily the creator's fault.

What we can flag is the promotional structure itself. Posting personal phone numbers and a physical address alongside weight loss hashtags on TikTok is a common pattern for medspa marketing that skirts the line between social media content and direct medical solicitation. The Federal Trade Commission and FDA have both issued guidance warning that health service advertising must not be misleading, and that testimonial-style promotions require disclosure of material connections (FTC, 2023 updated guidelines).

The #armonizacionfacial hashtag suggests this account covers cosmetic injectables as well. Bundling facial aesthetics with weight loss under the same promotional umbrella is a known medspa marketing pattern that doesn't necessarily reflect integrated clinical care. That's worth knowing before you call either of those numbers.

What should you actually know?

If you're looking at a TikTok that leads with a medspa address and two phone numbers, you are looking at an advertisement, not health content. That's not an insult to the creators. It's just accurate framing.

GLP-1 medications are real, effective, and FDA-approved for specific indications. Semaglutide (Wegovy) is approved for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition (FDA, 2021). Tirzepatide (Zepbound) received similar approval in 2023. These are prescription medications that require proper evaluation, not something to initiate based on a social media ad.

Compounded versions of semaglutide have been widely marketed through medspas and telehealth platforms. Compounded drugs are not FDA-approved, are not equivalent to brand-name products, and carry variable quality risks. The FDA has repeatedly warned consumers about this (FDA Drug Safety Communication, 2023).

• Always ask whether a prescriber is licensed in your state and what credentials they hold.
• Ask specifically whether the product is brand-name or compounded, and from which pharmacy.
• A legitimate provider will conduct a medical history review before prescribing any GLP-1 medication.
• TikTok promotions with phone numbers are ads. Treat them like ads.